Just - Evotec Biologics

Just - Evotec Biologics

Biotechnology Research

Seattle, WA 14,324 followers

Designing and applying innovative technologies to dramatically expand global access to biotherapeutics.

About us

Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is to accelerate and expand access to biotherapeutics through scientific and technological innovation for our proprietary projects and on behalf of our partners. Learn more at www.just-evotecbiologics.com

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
Seattle, WA
Type
Public Company
Founded
2014
Specialties
Molecule Design/ Engineering, Process Development, Analytical Development, Formulation & Drug Product Development, Clinical Manufacturing, Discovery Services, Preclinical Manufacturing, cGMP Manufacturing, CDMO Services, Biosimilars, Antibody therapeutics, biologics manufacturing, cell line development, Biotherapeutics, Biologics, and Biomanufacturing

Locations

Employees at Just - Evotec Biologics

Updates

  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Transforming Antibody Manufacturing with Continuous Biomanufacturing Exciting news! Our team at Just - Evotec Biologics has achieved remarkable results in the rapid conversion of an intensified fed-batch (IFB) antibody manufacturing process to an integrated continuous biomanufacturing (ICB) process. Download the poster here: https://hubs.ly/Q02LpFRZ0 Key Accomplishments: 1. Mitigation of Upstream IFB Challenges: We successfully addressed challenges related to IFB processes, ensuring smoother production and consistent quality with ICB. 2. Significant Productivity Increase: By adopting the ICB platform, we witnessed a substantial boost in productivity, allowing us to meet demand efficiently. 3. Short Development Time: Our streamlined approach significantly reduced development timelines, accelerating the transition from fed-batch to continuous manufacturing. 4. Minimal Risk from Quality Changes: The robustness of the ICB platform ensured that product quality remained unaffected during the conversion process. These results underscore the potential of continuous biomanufacturing in the biotherapeutics industry. As clinical and business circumstances evolve, our ability to adapt quickly becomes crucial. #Biomanufacturing #Innovation #Biotherapeutics #ContinuousBioanufacturing #JustEvotecBiologics Feel free to share this exciting breakthrough with your network!

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Are you looking to maximize productivity in biologics manufacturing? Don’t miss this webinar on “Biologics Manufacturing: Maximizing Productivity Using Process Intensification”. Date: Thursday, October 17, 2024 Time: 8:00 am PT | 11:00 am ET | 17:00 CET In this webinar, industry experts from Sanofi, Sartorius and Just – Evotec Biologics will share insights on: • Innovative strategies for process intensification • Enhancing efficiency and productivity in biologics manufacturing • Real-world case studies and best practices Whether you’re a seasoned professional or new to the field, this webinar is a fantastic opportunity to learn and network with peers. Register Now- https://hubs.ly/Q02TB9h20 Don’t miss out on this chance to stay ahead in the rapidly evolving field of biologics manufacturing. See you there! #Biologics #Continuousmanufacturing #Webinar #ProcessIntensification #Productivity #Pharmaceuticals #Biotech #JustEvotecBiologics

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Exciting News... Join Us at BIO-Europe 2024! Meet us at the conference to learn more about J.POD® Toulouse and our commitment to advancing the continuous biomanufacturing of biologics. What’s J.POD® Toulouse? J.POD® Toulouse, located in France (EU), is the first European facility of its kind. It employs Just – Evotec Biologics’ innovative J.POD® technology, revolutionizing biologics manufacturing. Why Is This Important? Biologics are powerful therapies with broad applications across various medical fields. However, traditional manufacturing methods face challenges during scale-up from clinical to commercial supply. J.POD® technology offers a solution: a modular continuous manufacturing setup that allows for highly intensified, flexible production of biologics - and it's now open for you to tour! Schedule a meeting: https://hubs.ly/Q02T7lvY0 Let’s shape the future of healthcare together! #JustEvotecBiologics #Biologics #Innovation #ContinuousBiomanufacturing #BIOEurope2024

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Join us in-person in Leesburg, Virginia at Integrated and Continuous Biomanufacturing (ICB) event this month! - Developing ICB Business Cases (Roundtable Workshop) - Date and Time: Monday, 21 October, 2:00 pm - Co-chairs: Suzy Farid, UCL and Eva Gefroh, Just - Evotec Biologics - Low Pressure Operations as Worst-Case Situations for Viral Filtration - Date and Time: Monday, 21 October, 5:25 pm - Presenter: Megan McClure, Senior Principal Scientist Process & Product Design, Seattle - Environmental impact evaluation of fed-batch vs intensified, continuous mAb manufacturing with a life cycle assessment tool - Date and Time: Tuesday, 22 October, 1:05 pm - Presenter: Lisa Connell-Crowley, SVP Process & Product Design Process & Product Design, Seattle - Defining an ideal future for reduction, recycling and circularity of single use plastics - Date and Time: Tuesday, 22 October, 1:45 pm - Presenter: Lisa Connell-Crowley, SVP Process & Product Design Process & Product Design, Seattle Arrange a meeting with our experts: https://hubs.ly/Q02T6Kk-0 #ContinuousBiomanufacturing #JustEvotecBiologics #EngineeringConferenceInternational

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Our J. MD™ Molecular Design service helps derisk CMC efforts by helping biopharma companies select an optimal lead candidate and optimize the molecular design of biologics to ensure manufacturability, stability, and efficacy from the earliest stages of development. How? Read our blog to find out: https://hubs.ly/Q02SFGgt0 Contact us: info@evotec.com #JustEvotecBiologics #ContinuousBiomanufacturing #Developability #Preclinical

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Join us at CPHI to explore how our new J.POD in Toulouse is revolutionizing biomanufacturing! Just – Evotec Biologics was thrilled to announce the opening of our cutting-edge J.POD Toulouse facility in France on September 20th! This state-of-the-art facility is the first of its kind in Europe, and it’s poised to transform biomanufacturing. J.POD Toulouse provides innovative process development and manufacturing all under one roof. Take, for example, our J.CHO™ High Expression System that is delivering extraordinary titers within our continuous manufacturing platform. Meet our experts at CPHI Milan to dive deeper. Schedule a meeting with our experts here- https://hubs.ly/Q02S9fV-0 Let’s shape the future of biomanufacturing together! #CPHI2024 #JPODToulouse #JustEvotecBiologics #Continuousbiomanufacturing

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Just - Evotec Biologics has taken a significant step towards leveraging AI and ML for biopharmaceutical discovery by creating a Humanoid Antibody Library. In our latest publication, we describe the validation of this library by isolating antibodies against a target of pandemic concern, SARS-CoV-2. We successfully identified a panel of human monoclonal antibodies that are novel, diverse, and pharmacologically active. These first-generation antibodies exhibited neutralization of SARS-CoV-2 viral infectivity across multiple strains and indicated high developability potential. These results demonstrate the applicability of our platform for effective therapeutic antibody discovery. Read more here- https://hubs.ly/Q02SjSml0 #MachineLearning #AI #Biopharmaceuticals #Therapeutics #SARSCoV2 #AntibodyDiscovery #JustEvotecBiologics

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Watch our video on #continuousbiomanufacturing for first-in-human clinical trial supply as we discuss how high productivity production runs are revolutionizing early phase clinical trials by eliminating unnecessary batches, improving quality and saving time so that emerging biopharma companies can invest more in additional R&D, clinical trials and extend their funding runway. Contact us at info@evotec.com #biomanufacturing #IND #FirstInHuman #JustEvotecBiologics

  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Just - Evotec Biologics is thrilled to announce our participation in the upcoming Integrated Continuous Biomanufacturing Conference (ICB VI) hosted by Engineering Conference International! Date: Oct 20-24 Location: Leesburg, Virginia, USA ICB VI will bring together leading scientists and engineers from academia, industry, and regulatory bodies who are actively engaged in creating and enabling integrated continuous biomanufacturing. As global competitive pressures continue to force companies to innovate to succeed, integrated continuous processing creates opportunities to accelerate process development and reduce manufacturing costs while enhancing flexibility and product quality. Learn more about ICB VI here- https://hubs.ly/Q02RChRx0 Don’t miss the opportunity to connect with our team and learn more about our innovative solutions. Schedule Meeting here- https://hubs.ly/Q02RC3GL0 We look forward to meeting you there and driving forward the mission of continuous improvement in biomanufacturing together! #Biomanufacturing #Innovation #ContinuousImprovement #JustEvotecBiologics #EngineeringConferenceInternational

    • No alternative text description for this image
  • View organization page for Just - Evotec Biologics, graphic

    14,324 followers

    Just-Evotec Biologics is excited to announce our participation in BIOJAPAN 2024! Join us to discover our innovative #continuousbiomanufacturing platform and engage in discussions about the future of #biologics production. Our expert team is eager to share insights on how we’re advancing sustainable and efficient production processes. Event Date: October 9-11 Location: Pacifico Yokohama | Yokohama, Japan Schedule a meeting with us: https://hubs.ly/Q02RL17G0 Don’t miss the chance to connect with our experts and explore how Just-Evotec Biologics is shaping the future of biomanufacturing. See you there! #Biomanufacturing #Sustainability #BIOJAPAN2024 #Biotech

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs

Funding